Advertisement

The AACR remains fully committed to supporting publishing operations throughout this challenging time, while still remaining flexible and supportive of the author, reviewer, and editor communities that we serve. If you have any questions or concerns, please reach out to a member of the AACR publishing staff.
Please visit the COVID-19 & Cancer Resource Center where COVID-related content is freely available.

 

The First Lady Presses for Cancer Screening to Get Back On Track.
Read the commentary by Lisa A. DuBois and Raymond N. DuBois.

From the Current Issue

  • Research Briefs
    Intranasal Iloprost Prevents Tumors in a Murine Lung Carcinogenesis Model
    Meredith A. Tennis, Alex J. Smith, Lori D. Dwyer-Nield and Robert L. Keith
    Cancer Prev Res January 1 2022 15 (1) 11-16; DOI:10.1158/1940-6207.CAPR-21-0086

    Iloprost is a promising chemoprevention agent for lung cancer and this work describes a new delivery approach in vivo.

  • Research Article
    Single-cell RNA Sequencing Reveals How the Aryl Hydrocarbon Receptor Shapes Cellular Differentiation Potency in the Mouse Colon
    Yongjian Yang, Daniel Osorio, Laurie A. Davidson, Huajun Han, Destiny A. Mullens, Arul Jayaraman, Stephen Safe, Ivan Ivanov, James J. Cai and Robert S. Chapkin
    Cancer Prev Res January 1 2022 15 (1) 17-28; DOI:10.1158/1940-6207.CAPR-21-0378

    Our mouse single-cell RNA sequencing analyses provide new evidence of the molecular function of Ahr in modulating colonic stemness and cell–cell communication in vivo. From a cancer prevention perspective, Ahr should be considered a therapeutic target to recalibrate remodeling of the intestinal stem cell niche

  • Research Article | Open Access
    Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
    Alba L. Combita, Viviana Reyes, Devi Puerto, Raúl Murillo, Ricardo Sánchez, Marcela Nuñez, Gustavo A. Hernandez-Suarez and Carolina Wiesner
    Cancer Prev Res January 1 2022 15 (1) 55-66; DOI:10.1158/1940-6207.CAPR-21-0063

    Monitoring HPV vaccines post-licensure plays an important role in assessing the progress of immunization programs, demonstrating the impact of vaccines on the population, and providing data for policy needs. In Colombia, HPV vaccines showed effectiveness when administered before start of sexual activity, and two doses are sufficient to achieve good protection

OnlineFirst Articles

Load more

Trending - Altmetric

Advertisement

Back to top